Growth Metrics

Avanos Medical (AVNS) Net Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn -85.60%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -85.60%
Dec 31, 2025 -18.34%
Sep 30, 2025 -290.00%
Jun 30, 2025 -156.80%
Mar 31, 2025 -16.82%
Dec 31, 2024 209.05%
Sep 30, 2024 -118.59%
Jun 30, 2024 228.03%
Mar 31, 2024 67.48%
Dec 31, 2023 -404.35%
Sep 30, 2023 99.26%
Jun 30, 2023 -320.00%
Mar 31, 2023 -131.69%
Dec 31, 2022 -68.06%
Sep 30, 2022 1,787.50%
Jun 30, 2022 1,100.00%
Mar 31, 2022 -54.35%
Dec 31, 2021 129.88%
Sep 30, 2021 89.87%
Jun 30, 2021 89.09%
Mar 31, 2021 16.36%
Dec 31, 2020 -551.35%
Sep 30, 2020 88.98%
Jun 30, 2020 90.98%
Mar 31, 2020 70.51%
Dec 31, 2019 58.58%
Sep 30, 2019 39.70%
Jun 30, 2019 -118.20%
Mar 31, 2019 -86.50%
Dec 31, 2018 -150.19%
Sep 30, 2018 -1,190.83%
Jun 30, 2018 2,764.96%
Mar 31, 2018 -173.26%
Dec 31, 2017 78.00%
Sep 30, 2017 43.42%
Jun 30, 2017 113.67%
Mar 31, 2017 -20.87%
Dec 31, 2016 74.42%
Sep 30, 2016 7,500.00%
Jun 30, 2016 -65.89%
Mar 31, 2016 84.49%
Dec 31, 2015 -81.28%
Sep 30, 2015 -98.96%
Jun 30, 2015 -500.00%
Mar 31, 2015 333.75%
Dec 31, 2014 5,843.75%